Creative Biolabs-Immuno-oncology

Anti-EGLN1 (clone AT2E1GE9Q) SynExpress E1-mKa-cJ-K Modified CD8+ T cells (CAT#: ITS-1224-CR2579)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target EGLN1 (clone AT2E1GE9Q). We employs the Retrovirus (EF1α-mKate-c-Jun-KpnI) vector components and the SynExpress system of the Single base pair Knockout/Negative feedback for a robust and sustained response against cancers.
Host
Mouse
Target
EGLN1
Clone
AT2E1GE9Q
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
mKate
Promoter
EF1α
Effector Gene
c-Jun
Insertion Sites
KpnI
Gene Modification
Knockout
Modification Domain
Single base pair
Carrier Type
Retrovirus
Transformation Accuracy
0.94
Cell Culture
Suspension Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.
Close
Thanksgiving
Thanksgiving